key: cord-0950041-fwocvzc1
authors: Johnson, Christine C.; Coleman, Chad M.; Sitarik, Alexandra R.; Leon, Joyce E.; Tibbetts, Robert J.; Cook, Bernard C.; Muma, Bruce K.; Weinmann, Allison J.; Samuel, Linoj P.
title: SARS-CoV-2 RT-PCR Positivity and Antibody Prevalence among Asymptomatic Hospital-Based Health Care Workers
date: 2021-03-16
journal: J Clin Virol
DOI: 10.1016/j.jcv.2021.104794
sha: 6371ed00efd915d1b5936c5e6dbd63309d29140b
doc_id: 950041
cord_uid: fwocvzc1

BACKGROUND: The level of asymptomatic infection with SARS-CoV-2 could be substantial and among health care workers (HCWs) a source of continuing transmission of the virus to patients and co-workers. OBJECTIVES: Measure the period prevalence of SARS-CoV-2 PCR positivity and seroprevalence of SARS-CoV-2 IgG antibodies among a random sample of asymptomatic health system hospital-based health care workers (HCWs) 6½ -15½ weeks after 4/5/2020, the peak of the first surge of COVID-19 admissions. RESULTS: Of 524 eligible and consented participants from four metropolitan hospitals, nasopharyngeal swabs were obtained from 439 (83.8%) and blood from 374 (71.4%). Using PCR nucleic acid-based amplification (NAAT) methods, the period prevalence of SARS-CoV-2 infection was 0.23% (95% confidence interval (CI) 0.01%-1.28%; 1/439) from 5/21/20-7/16/20. The seroprevalence of SARS-CoV-2 IgG antibodies from June 17-July 24, 2020 was 2.41% (95% CI 1.27%-4.51%; 9/374). Those who were reactive were younger (median age 36 versus 44 years; p = 0.050), and those with self-reported Hispanic/Latino ethnicity had a higher seroprevalence rate (2/12 = 16.7% versus 7/352 = 2.0%; p = 0.051). There were no significant differences by sex, race, residence, hospital, unit or job type. The one employee who was found to be PCR test positive in this study was also reactive for IgG antibodies, tested 27 days later. CONCLUSIONS: The period prevalence of PCR positivity to SARS-CoV-2 and IgG seroprevalence was unexpectedly low in asymptomatic HCWs after a peak in COVID-19 admissions and the establishment of state and institutional infection control policies, suggesting that routine screening tests while community prevalence is relatively low would produce a minimal yield.

44 years; p=0.050), and those with self-reported Hispanic/Latino ethnicity had a higher seroprevalence rate (2/12=16.7% versus 7/352=2.0%; p=0.051). There were no significant differences by sex, race, residence, hospital, unit or job type. The one employee who was found to be PCR test positive in this study was also reactive for IgG antibodies, tested 27 days later.

The period prevalence of PCR positivity to SARS-CoV-2 and IgG seroprevalence was unexpectedly low in asymptomatic HCWs after a peak in COVID-19 admissions and the establishment of state and institutional infection control policies, suggesting that routine screening tests while community prevalence is relatively low would produce a minimal yield.

Key Words: SARS-CoV-2; prevalence; health care workers Word Count= Abstract 250; Text 1472

As the novel SARS COV-2 virus began its sweep across the world in late 2019, health care workers (HCWs) were at risk of COVID-19 morbidity and mortality through work and community exposure as well as being potential transmission sources of nosocomial infection for patients and co-workers. 1, 2 Metropolitan Detroit, Michigan developed as a "hot spot" in March 2020, with the first two cases in the state confirmed on 3/10/20, statewide polices on social distancing and stay-in-place for non-essential workers mandated on 3/23/20, and the highest number of cases reached in early April 2020. 3 Henry Ford Health System (HFHS), had a peak number of COVID-19 inpatients (n=603) in its four metropolitan Detroit hospitals on 4/5/20. Stringent infection control policies were put in place as the pandemic progressed, including a universal masking policy on 4/7/20. 4 The number of inpatients dropped markedly until reaching lower rates in May 2020 (average COVID-19 bed census 68.4; 95% confidence interval (CI) 64. 5-72.4) . A recent meta-analysis of COVID-19 screening studies among asymptomatic HCWs across the world J o u r n a l P r e -p r o o f yielded an estimated pooled prevalence of 5% (95% confidence interval (CI) of 1-13), but the analysis included time periods of both peak and low community disease activity. 5 

To address concerns about hospital-based transmission, a study was designed to determine whether the prevalence of detectable SARS-CoV-2 among asymptomatic HCWs, during a postsurge period and as regular hospital activities resumed, justified the need for routine screening.

After the study started, a serology test became available, which was also offered to participants to evaluate the seroprevalence of IgG antibodies to the virus.

A list of employees actively working at the HFHS academic hospital and its 3 Detroit-area community hospitals in patient-facing clinical was created that included names, occupation, work location, email and phone number. A random sample was selected and invited to undergo testing for SARS-CoV-2 through the collection of nasopharyngeal (NP) swabs. Starting on 5/27/20, following a pilot study that began on 5/20/20, recruitment emails were sent in batches, followed by reminder emails and repeated phone contacts. Employees with any history of a COVID-19 diagnosis were ineligible. As of 6/15/20, the SARS-CoV-2 IgG antibodies test was also offered to new participants and those who had already provided NP samples.

The NP swabs were collected in saline transport vials and tested for SARS-CoV-2 using real- Non-parametric tests (Fisher's exact test and Kruskal-Wallis test), were used to assess differences between participants and non-participants and populations with positive versus negative test results. Prevalence estimates and 95% CIs were calculated. 6 All study processes and procedures were approved by the HFHS Institutional Review Board (IRB #13878) and electronic informed consents obtained.

After initial exclusions, our final sampling frame included 11,213 individuals ( Figure 1 ).

A sample of 72 HCWs was selected for the pilot study followed by a random sample of 2,500.

Of these, 1,130 could not be contacted or were determined to be ineligible. Of the remaining 1,442, 1,002 were contacted but did not enroll, while 440 (31%) consented and received at least one test. Statistically significant differences were found by hospital of employment and job function between those eligible and consented (n=524), those not successfully contacted (n=1,065), and those contacted who did not participate (n=918), both p<0.001. Nurses were the most difficult to contact, and managers and allied health staff were more likely to participate, while facility/security staff were less likely. Males were less likely to participate than females (p=0.059). A total of 373 had both tests completed (average of 18 days between NP swab and blood draw); 66 had only an NP swab collected and one participant only had a serology test.

There was one HCW with a positive NAAT test of 439 tested from 5/21/20-7/16/20. The period prevalence of positive NAAT tests among asymptomatic HCWs was 0.23% (95% CI 0.01%-1.28%).

J o u r n a l P r e -p r o o f Table 1 presents the characteristics of the 374 participants who provided blood samples from 6/17/20-7/24/20. Nine HCWs were reactive, corresponding to a seroprevalence of IgG to SARS-CoV-2 of 2.41% (95% CI 1.27%-4.51%). Those who were reactive were younger (median age 36 years versus 44.0 years; p=0.050), and those self-identified as Hispanic had a higher reactivity rate (16.7% versus 1.99%; p=0.051). There were no differences by sex, race, Middle Eastern ancestry, city residence, hospital of employment, job, or direct contact with COVID-19

patients.

The specimen of the one participant who had a positive NAAT test was collected in the end of May 2020, followed by a blood draw for an IgG antibodies test 27 days later, which was also positive. The SARS anti-IgG assay we used demonstrated 100% PPV at 14 days post-PCR at our overall PCR positive rate of 5.9% during assay validation (data not shown). The low prevalence of PCR positivity in our asymptomatic HCW population of 0.23% would reduce the PPV to approximately 22%, with an NPV of 100%. J o u r n a l P r e -p r o o f 11 followed through first pandemic wave *self collected nose and throat swab **either IgA, IgM or IgG reactive ***7 were positive but uncertain whether these individuals previously symptomatic or not; all cultured and negative. Table 2 . Studies of SARS-CoV-2 detection by RT-PCR and IgG antibody seroprevalence among asymptomatic HCWs J o u r n a l P r e -p r o o f Like others, we found a higher prevalence in younger HCWs. 11, 13 One other US study of both symptomatic and asymptomatic HCWs reported a higher prevalence of SARS-CoV-2 IgG antibodies among Hispanic/Latinos employees, 13 perhaps reflecting the higher community COVID-19 incidence in this group. 23, 24 Direct COVID-19 patient exposure was not associated with prevalence; that and an infection prevalence similar to the community implies the effectiveness of infection control policies. Some have reported increased detection of SARS antibodies by combining IgM and IgG results from separate assays. 25 In similar fashion, using a dual serology algorithmic approach may increase detection capability. At the time of this study, the IgG assay used for this study was the only assay in our laboratory. Since then, we have added testing for total SARS antibodies (IgG+IgM) using the Cobas SARS-CoV-2 Total antibodies assay and automated high-throughput e801 analyzers (Roche Diagnostics, Indianapolis, IN). Early findings in a study of initial and sustained antibodies to COVID-19 have demonstrated 98.6% agreement of the two serologic assays, making a dual testing approach of minimal value in our setting (data not shown).

Limitations of this study included a longer time to enroll participants than expected, stretching out the period of prevalence, an inability to contact many of those selected to participate and a higher than expected number of refusals. We suspect that many of those who could not be contacted were passive refusals. At the time of the study, it is probable that HCWs felt less fearful of being infected, as well as fatigued from research requests and COVID-related concerns. The low prevalence of COVID-19 in our asymptomatic HCWs also means that some These results demonstrate that the prevalence of COVID among asymptomatic HCW's after a local pandemic surge and after implementation of COVID protection policies was similar or even lower to that seen in the community. These results support others recommending that at times of low community prevalence of SARS CoV-2, and given the need to conserve testing supplies and reagents to maintain a reserve capacity along with the high potential for false-positive tests;

it is not effective to routinely screen asymptomatic HCWs as long as COVID-19 protection policies are in place. 18, 26, 27 Declaration of Competing Interest This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors but was accomplished using institutional funds.

The authors have no conflicts of interest. 

Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review

Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. Elife

Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve

COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes

Approximate is better than "exact" for interval estimation of binomial proportions

SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients

COVID-19: PCR screening of asymptomatic health-care workers at London hospital. Lancet

Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff

Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study

Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy

Prevalence of SARS-CoV-2 Infection Among Asymptomatic Health Care Workers in the Greater

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust

Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff

No cases of asymptomatic SARS-CoV-2 infection among healthcare staff in a city under lockdown restrictions: lessons to inform 'Operation Moonshot'. J Public Health (Oxf)

Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain

Risk Assessment and seroprevalence of SARS CoV2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland. The Lancet Regional Health Europe Elsevier 2021

SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study

Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US

Test performance evaluation of SARS-CoV-2 serological assays. medRxiv

Monitoring approaches for health-care workers during the COVID-19 pandemic

Asymptomatic health-care worker screening during the COVID-19 pandemic